Your Pharmacy Can Fund Your Mission: The Strategic Case for AI in Health System Pharmacy
By Kim Tzoumakas, CEO, VytlOne Overview Health system pharmacy is one of the few growth levers a nonprofit or safety-net
VytlOne
VytlOne
How To Avoid 30-Day Readmission Medicare/Medicaid Penalties
What is the Hospital Readmissions Reduction Program? HRRP is a value-based Medicare purchasing program that encourages hospitals to improve communication
Embracing AI Without Losing the Human Touch
A VytlOne Member Services Success Story What is responsible AI in pharmacy? Responsible AI in pharmacy means using artificial intelligence
340B, Blog, VytlOne
How HRSA’s Rebate Model Pilot Program Could Destroy 340B
Has your health system prepared for HRSA’s forthcoming 340B Rebate Model Pilot Program, scheduled to begin January 1, 2026? We
340B, Blog, VytlOne
Bausch Has Pulled Its Drug Catalog From The 340B Program.
What Bausch’s exit from the 340B program means for hospitals and patients. It would not be an exaggeration to say
340B, Blog, VytlOne
The Holistic Pharmacy Approach To 340B Patient Support
How to make Pharmacy “The Easy Part” of the patient experience. Anyone who’s ever been a hospital patient, or patient
340B, Blog, VytlOne
Optimize 340B Program Savings & Compliance With Data Mining
Since late 2019, VytlOne has supported the 340B programs of 33 health systems and 38 health centers. Altogether, we’ve generated
340B, Blog, VytlOne
How One Clinical Pharmacist Can Impact Hospital Readmissions
There are so many reasons Brandi Henneman has had such a positive impact on participation rates for VytlOne’s Readmission Reduction
340B, Blog, VytlOne
Why 340B Hospitals Should Now Build Their Own Specialty Pharmacies
URAC Accredited The VytlOne specialty pharmacy team is accredited by URAC (Utilization Review Accreditation Commission), the medical profession’s gold standard
340B, Blog, VytlOne
How 340B Programs Can Positively Impact Value-Based Care Scores
It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based